| Sign In to gain access to subscriptions and/or personal tools. |
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial diseaseDepartment of Internal Medicine, School of Medicine, University of Catania, Catania, Italy, ssignore{at}unict.it
Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy
Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy
Department of Internal Medicine, School of Medicine, University of Catania, Catania, Italy
Department of Internal Medicine, School of Medicine, University of Catania, Catania, Italy
Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy
Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy
Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy
Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy
Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy, Department of Microbiology & Immunology, Brody School of Medicine at East Carolina University, Greenville, NC, USA
Department of Internal Medicine, School of Medicine, University of Catania, Catania, Italy
Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy Deregulation of matrix metalloproteinases (MMPs) is an important factor contributing to the development of vascular lesions. Plasma levels and zymographic activities of MMP-2 and MMP-9 were investigated in type II diabetics with (n = 51) or without (n = 42) peripheral artery disease (PAD) and in normal volunteers (n = 23). Plasma MMP-2 levels were higher in type II diabetics with (p < 0.01) or without (p < 0.05) PAD in comparison with normal volunteers. Similarly, type II diabetics with (p < 0.0001) or without (p > 0.05) PAD had higher plasma MMP-9 levels than normal volunteers. Plasma zymographic activities of both MMP-2 and MMP-9 were positively correlated with their plasma levels. Plasma MMP-2 zymographic activity was higher in type II diabetics with PAD than type II diabetics without PAD (p > 0.05). Plasma MMP-9 zymographic activity was higher in type II diabetics with (p < 0.0001) or without (p < 0.0001) PAD in comparision with normal volunteers. Together, these results indicate that increased plasma levels and zymographic activities of MMP-2 and MMP-9 may contribute to PAD in type II diabetics. In particular, plasma MMP-9 may be a useful marker for the development of vascular disease in type II diabetics.
Key Words: MMP-2 MMP-9 type II diabetes vascular disease
Vascular Medicine, Vol. 10, No. 1,
1-6 (2005) This article has been cited by other articles:
|
|||||||||||||||||||||||||||

